Ledipasvir/sofosbuvir for 8 or 12 weeks in GT1 HCV-infected, treatment-naive and non-cirrhotic patients with HIV infection: real-world experience from the MADRID-CoRe study
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY(2016)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined